Seneca House Advisors Bristol Myers Squibb CO Transaction History

Seneca House Advisors

$244 Million
Q4 2024

A detailed history of Seneca House Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Seneca House Advisors holds 4,416 shares of BMY stock, worth $265,048. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,416

Previous 4,266 3.52%

Holding current value

$265,048

Previous $220,000 13.18%

% of portfolio

0.1%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$51.92 - $59.94 $7,788 - $8,991	150 Added 3.52%	4,416 $249,000
Q3 2024 Oct 04, 2024	BUY	$39.66 - $51.75 $169,189 - $220,765	4,266 New	4,266 $220,000
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $1,679 - $1,904	-35 Reduced 0.83%	4,165 $225,000
Q4 2023 Jan 09, 2024	SELL	$48.48 - $57.85 $10,762 - $12,842	-222 Reduced 5.02%	4,200 $215,000
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $3,473 - $3,883	60 Added 1.38%	4,422 $256,000
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $7,008 - $7,781	-110 Reduced 2.46%	4,362 $278,000
Q1 2023 Apr 11, 2023	BUY	$65.71 - $74.53 $197 - $223	3 Added 0.07%	4,472 $309,000
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $68,685 - $81,333	1,003 Added 28.94%	4,469 $321,000
Q3 2022 Oct 07, 2022	BUY	$0.13 - $76.84 $0 - $230	3 Added 0.09%	3,466 $246,000
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $21,640 - $23,834	298 Added 9.42%	3,463 $267,000
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $194,584 - $233,323	3,165 New	3,165 $231,000
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $186,681 - $218,673	-3,155 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $866 - $943	-14 Reduced 0.44%	3,155 $211,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $12,936 - $14,549	-218 Reduced 6.44%	3,169 $200,000
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $30,140 - $34,154	-522 Reduced 13.35%	3,387 $210,000
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $14,185 - $15,719	-247 Reduced 5.94%	3,909 $236,000
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $1,589 - $1,858	29 Added 0.7%	4,156 $244,000
Q1 2020 Apr 09, 2020	SELL	$46.4 - $67.43 $15,404 - $22,386	-332 Reduced 7.45%	4,127 $230,000
Q4 2019 Jan 13, 2020	BUY	$49.21 - $64.19 $49 - $64	1 Added 0.02%	4,459 $286,000
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $40,075 - $47,515	-937 Reduced 17.37%	4,458 $226,000
Q2 2019 Jul 23, 2019	SELL	$44.62 - $49.34 $10,262 - $11,348	-230 Reduced 4.09%	5,395 $238,000
Q1 2019 Apr 22, 2019	BUY	$45.12 - $53.8 $20,078 - $23,941	445 Added 8.59%	5,625 $268,000
Q4 2018 Jan 14, 2019	BUY	$48.76 - $63.23 $6,875 - $8,915	141 Added 2.8%	5,180 $269,000
Q3 2018 Oct 19, 2018	SELL	$55.19 - $62.25 $13,907 - $15,687	-252 Reduced 4.76%	5,039 $313,000
Q2 2018 Jul 23, 2018	SELL	$50.53 - $62.98 $85,901 - $107,066	-1,700 Reduced 24.32%	5,291 $293,000
Q1 2018 Apr 12, 2018	SELL	$59.92 - $68.98 $18,754 - $21,590	-313 Reduced 4.29%	6,991 $442,000
Q4 2017 Feb 20, 2018	BUY	$59.94 - $65.35 $437,801 - $477,316	7,304	7,304 $448,000

Others Institutions Holding BMY

# of Institutions

2,765

Shares Held

1.56B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $128B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seneca House Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Seneca House Advisors with notifications on news.

Account

Seneca House Advisors Bristol Myers Squibb CO Transaction History